Esperance Anne Kreek Schaefer, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepacivirus | 18 | 2022 | 1336 | 1.740 |
Why?
|
Hepatitis, Alcoholic | 2 | 2024 | 109 | 0.960 |
Why?
|
Liver Diseases, Alcoholic | 2 | 2023 | 156 | 0.920 |
Why?
|
Hepatitis C, Chronic | 5 | 2019 | 1032 | 0.870 |
Why?
|
Hepatitis C | 10 | 2022 | 1584 | 0.820 |
Why?
|
Virus Replication | 9 | 2019 | 2435 | 0.700 |
Why?
|
Hepatitis B | 3 | 2022 | 705 | 0.670 |
Why?
|
Jaundice | 2 | 2019 | 94 | 0.660 |
Why?
|
Hepatitis D | 1 | 2019 | 23 | 0.660 |
Why?
|
End Stage Liver Disease | 1 | 2023 | 352 | 0.630 |
Why?
|
Hepatocytes | 6 | 2022 | 1233 | 0.560 |
Why?
|
Hepatitis B, Chronic | 1 | 2021 | 410 | 0.560 |
Why?
|
Apolipoprotein B-100 | 1 | 2016 | 157 | 0.530 |
Why?
|
Virus Internalization | 2 | 2016 | 497 | 0.500 |
Why?
|
Pyrophosphatases | 1 | 2011 | 142 | 0.380 |
Why?
|
Interleukins | 2 | 2014 | 782 | 0.360 |
Why?
|
Drugs, Investigational | 1 | 2012 | 212 | 0.340 |
Why?
|
Hepatitis, Autoimmune | 1 | 2012 | 172 | 0.330 |
Why?
|
Lipase | 1 | 2011 | 325 | 0.330 |
Why?
|
Liver | 7 | 2024 | 7528 | 0.320 |
Why?
|
Antiviral Agents | 6 | 2016 | 3060 | 0.310 |
Why?
|
Interferon-alpha | 4 | 2019 | 921 | 0.310 |
Why?
|
RNA, Viral | 1 | 2016 | 2846 | 0.300 |
Why?
|
Lipid Metabolism | 2 | 2013 | 1902 | 0.300 |
Why?
|
Host-Pathogen Interactions | 2 | 2013 | 1459 | 0.300 |
Why?
|
Liver Cirrhosis | 4 | 2022 | 1935 | 0.280 |
Why?
|
Liver Function Tests | 3 | 2023 | 523 | 0.260 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2022 | 629 | 0.250 |
Why?
|
Liver Diseases | 3 | 2023 | 1297 | 0.220 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2022 | 223 | 0.180 |
Why?
|
Complement System Proteins | 1 | 2024 | 735 | 0.180 |
Why?
|
Viral Nonstructural Proteins | 2 | 2012 | 227 | 0.180 |
Why?
|
Interferons | 3 | 2014 | 706 | 0.170 |
Why?
|
Hepatic Stellate Cells | 2 | 2022 | 119 | 0.170 |
Why?
|
Fatty Acids | 2 | 2021 | 1808 | 0.170 |
Why?
|
Proteomics | 2 | 2024 | 3848 | 0.170 |
Why?
|
Hepatitis B virus | 2 | 2022 | 528 | 0.150 |
Why?
|
Heroin Dependence | 1 | 2019 | 172 | 0.150 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 687 | 0.150 |
Why?
|
Gene Knockout Techniques | 2 | 2022 | 802 | 0.150 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 867 | 0.140 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 283 | 0.140 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2016 | 58 | 0.140 |
Why?
|
Ethanol | 1 | 2023 | 1324 | 0.140 |
Why?
|
Hepatolenticular Degeneration | 1 | 2017 | 72 | 0.140 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2016 | 94 | 0.130 |
Why?
|
Ribonucleoprotein, U5 Small Nuclear | 1 | 2015 | 8 | 0.130 |
Why?
|
Macrophage Activation | 1 | 2018 | 553 | 0.130 |
Why?
|
Peptide Elongation Factors | 1 | 2015 | 62 | 0.120 |
Why?
|
Piperidines | 1 | 2023 | 1656 | 0.120 |
Why?
|
Liver Failure, Acute | 1 | 2017 | 181 | 0.120 |
Why?
|
Doxycycline | 1 | 2017 | 344 | 0.120 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 2014 | 75 | 0.120 |
Why?
|
Membrane Proteins | 1 | 2011 | 7859 | 0.120 |
Why?
|
Substance Abuse, Intravenous | 1 | 2019 | 529 | 0.120 |
Why?
|
STAT1 Transcription Factor | 2 | 2014 | 341 | 0.120 |
Why?
|
Endoribonucleases | 1 | 2016 | 228 | 0.110 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2016 | 441 | 0.110 |
Why?
|
Minority Groups | 1 | 2021 | 1203 | 0.110 |
Why?
|
Spliceosomes | 1 | 2014 | 130 | 0.110 |
Why?
|
Unfolded Protein Response | 1 | 2016 | 234 | 0.110 |
Why?
|
Gastric Mucosa | 1 | 2017 | 604 | 0.110 |
Why?
|
Duodenum | 1 | 2017 | 490 | 0.110 |
Why?
|
Oligonucleotides | 1 | 2016 | 582 | 0.110 |
Why?
|
Cell Line | 6 | 2019 | 15601 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2021 | 11904 | 0.110 |
Why?
|
NF-kappa B | 3 | 2016 | 2490 | 0.110 |
Why?
|
HIV | 2 | 2018 | 1582 | 0.100 |
Why?
|
Lipoproteins, VLDL | 1 | 2013 | 201 | 0.100 |
Why?
|
Desmosterol | 1 | 2012 | 3 | 0.100 |
Why?
|
Cyclophilins | 1 | 2012 | 48 | 0.100 |
Why?
|
MicroRNAs | 2 | 2019 | 3816 | 0.100 |
Why?
|
DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Synthase | 1 | 2011 | 15 | 0.100 |
Why?
|
Deoxyribonucleases | 1 | 2012 | 211 | 0.100 |
Why?
|
Pyrimidines | 1 | 2023 | 3028 | 0.090 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2012 | 175 | 0.090 |
Why?
|
Humans | 31 | 2024 | 761596 | 0.090 |
Why?
|
Transcriptional Activation | 1 | 2016 | 1756 | 0.090 |
Why?
|
RNA Splicing | 1 | 2014 | 918 | 0.090 |
Why?
|
Viral Proteins | 1 | 2016 | 1804 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2822 | 0.080 |
Why?
|
Lactones | 1 | 2011 | 317 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2017 | 1161 | 0.080 |
Why?
|
Interferon Type I | 1 | 2012 | 562 | 0.080 |
Why?
|
Protease Inhibitors | 1 | 2011 | 754 | 0.080 |
Why?
|
Antigens, CD | 1 | 2018 | 4001 | 0.070 |
Why?
|
Fatty Liver | 1 | 2013 | 790 | 0.070 |
Why?
|
Drug Resistance, Viral | 1 | 2012 | 862 | 0.070 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 1993 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12973 | 0.070 |
Why?
|
Ultrasonography | 1 | 2019 | 5971 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2017 | 3032 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2015 | 1590 | 0.060 |
Why?
|
Mass Screening | 1 | 2021 | 5429 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2013 | 1964 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2023 | 15843 | 0.060 |
Why?
|
RNA, Small Interfering | 4 | 2016 | 3430 | 0.060 |
Why?
|
Cholesterol | 1 | 2013 | 2905 | 0.060 |
Why?
|
Proteome | 2 | 2024 | 1862 | 0.050 |
Why?
|
Autoantibodies | 1 | 2012 | 2118 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2015 | 3066 | 0.050 |
Why?
|
Organic Anion Transporters, Sodium-Dependent | 1 | 2022 | 26 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6312 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 151 | 0.050 |
Why?
|
Signal Transduction | 3 | 2014 | 23447 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2014 | 2297 | 0.050 |
Why?
|
Cell Line, Tumor | 4 | 2022 | 16990 | 0.050 |
Why?
|
Middle Aged | 7 | 2024 | 220921 | 0.050 |
Why?
|
Disease Progression | 2 | 2021 | 13510 | 0.040 |
Why?
|
Stem Cells | 1 | 2012 | 3524 | 0.040 |
Why?
|
Symporters | 1 | 2022 | 363 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7406 | 0.040 |
Why?
|
Genes, Regulator | 1 | 2019 | 373 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2014 | 4317 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8554 | 0.040 |
Why?
|
Genotype | 1 | 2011 | 12990 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3246 | 0.040 |
Why?
|
Activating Transcription Factor 6 | 1 | 2016 | 29 | 0.030 |
Why?
|
Pyruvate Kinase | 1 | 2018 | 189 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8002 | 0.030 |
Why?
|
Male | 7 | 2024 | 360846 | 0.030 |
Why?
|
eIF-2 Kinase | 1 | 2016 | 145 | 0.030 |
Why?
|
Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 2014 | 17 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2832 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 462 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1787 | 0.030 |
Why?
|
Actins | 1 | 2022 | 2050 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2017 | 300 | 0.030 |
Why?
|
Time Factors | 2 | 2014 | 39969 | 0.030 |
Why?
|
Animals | 3 | 2021 | 168475 | 0.030 |
Why?
|
United States | 1 | 2021 | 72340 | 0.030 |
Why?
|
Alcoholism | 1 | 2024 | 1973 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5672 | 0.030 |
Why?
|
Acetaminophen | 1 | 2017 | 555 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 1341 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15936 | 0.020 |
Why?
|
Phosphorylation | 2 | 2014 | 8321 | 0.020 |
Why?
|
HIV Infections | 1 | 2018 | 17354 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2023 | 64685 | 0.020 |
Why?
|
Female | 7 | 2024 | 392705 | 0.020 |
Why?
|
Models, Biological | 2 | 2021 | 9469 | 0.020 |
Why?
|
Autophagy | 1 | 2019 | 1327 | 0.020 |
Why?
|
Abdomen | 1 | 2017 | 1128 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2017 | 874 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2011 | 532 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2019 | 18966 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1612 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2012 | 452 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17904 | 0.020 |
Why?
|
Cell Movement | 1 | 2022 | 5205 | 0.020 |
Why?
|
Protein Binding | 2 | 2012 | 9353 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3517 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4021 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2015 | 1410 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2012 | 616 | 0.020 |
Why?
|
Aged | 4 | 2024 | 169310 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2139 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11076 | 0.020 |
Why?
|
Adult | 4 | 2024 | 221210 | 0.020 |
Why?
|
Metformin | 1 | 2013 | 906 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9420 | 0.020 |
Why?
|
Melanoma | 1 | 2023 | 5709 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2017 | 2330 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2016 | 3113 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2011 | 2192 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5767 | 0.010 |
Why?
|
Prognosis | 1 | 2024 | 29629 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18255 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10766 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6864 | 0.010 |
Why?
|
Biopsy | 1 | 2013 | 6766 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 59260 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4425 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 12794 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10508 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22176 | 0.010 |
Why?
|
Adolescent | 2 | 2017 | 88326 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39106 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81539 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 80647 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 30053 | 0.000 |
Why?
|